Mortality and cost of therapy of carbapenem susceptible vs resistant Gram-negative infections among hospitalised patients in India: a multicentric surveillance (2022–2025)
Nitin Bansal, Sonam Vijay, V. Ramasubramanian, Camilla Rodrigues, Prabhat Kumar, Bhawna Yadav, V.C. Ohri, Kamini Walia, Ambuj Yadav, Ambuj Yadav, Amit Gupta, Amit Kumar, Anju Susan Jacob, Aparna Chakraborty, Aparna Sonowal, Apurba Sankar Sastry, Arya Kumar, Ashish Bhalla, Ashok Kumar Pannu, Ashwani Gupta, Asim Kundu, Ayesha Sunavala, Babita Gupta, Balaji Veeraraghavan, Bashir Fomda, Bhanu Kumar, Bharti Taksande, Binila Chacko, Brijendra Kumar Rao, Chand Wattal, Chhavi Sawhney, Chiranjay Mukhopadhyay, D Himanshu Reddy, Daisy Phukan, Deepak Aggarwal, Deepak Gupta, Deepak Kumar, Deepthi Avvaru, Durga Shankar Meena, Gopal Krishana Bohra · 2026
Read Mortality and cost of therapy of carbapenem susceptible vs resistant Gram-negative infections among hospitalised patients in India: a multicentric surveillance (2022–2025) by Nitin Bansal, Sonam Vijay, V. Ramasubramanian, Camilla Rodrigues, Prabhat Kumar, Bhawna Yadav, V.C. Ohri, Kamini Walia, Ambuj Yadav, Ambuj Yadav, Amit Gupta, Amit Kumar, Anju Susan Jacob, Aparna Chakraborty, Aparna Sonowal, Apurba Sankar Sastry, Arya Kumar, Ashish Bhalla, Ashok Kumar Pannu, Ashwani Gupta, Asim Kundu, Ayesha Sunavala, Babita Gupta, Balaji Veeraraghavan, Bashir Fomda, Bhanu Kumar, Bharti Taksande, Binila Chacko, Brijendra Kumar Rao, Chand Wattal, Chhavi Sawhney, Chiranjay Mukhopadhyay, D Himanshu Reddy, Daisy Phukan, Deepak Aggarwal, Deepak Gupta, Deepak Kumar, Deepthi Avvaru, Durga Shankar Meena, Gopal Krishana Bohra (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13546927.txt.
Description
Bansal and a large team tracked what drug resistance costs in lives and cash in Indian hospitals. Their 2026 study used a national watch network of twenty large hospitals. It drew on case records from April 2022 to April 2025. The team found more than twenty-six thousand infections from gram-negative germs, a broad group of bacteria. It then matched deaths and drug costs for germs that resist key drugs with those that do not.
Death risk was higher for resistant infections for each of the four main germs in the study. The worst deaths came from resistant germs in the blood, where close to half of patients died. Drug costs ran up to twice as high for resistant cases as for plain cases. The team calls for tighter checks to stop infections and fair access to drugs that still work. It also backs strict rules on antibiotic use.
Catalog record
| CREATOR | Nitin Bansal, Sonam Vijay, V. Ramasubramanian, Camilla Rodrigues, Prabhat Kumar, Bhawna Yadav, V.C. Ohri, Kamini Walia, Ambuj Yadav, Ambuj Yadav, Amit Gupta, Amit Kumar, Anju Susan Jacob, Aparna Chakraborty, Aparna Sonowal, Apurba Sankar Sastry, Arya Kumar, Ashish Bhalla, Ashok Kumar Pannu, Ashwani Gupta, Asim Kundu, Ayesha Sunavala, Babita Gupta, Balaji Veeraraghavan, Bashir Fomda, Bhanu Kumar, Bharti Taksande, Binila Chacko, Brijendra Kumar Rao, Chand Wattal, Chhavi Sawhney, Chiranjay Mukhopadhyay, D Himanshu Reddy, Daisy Phukan, Deepak Aggarwal, Deepak Gupta, Deepak Kumar, Deepthi Avvaru, Durga Shankar Meena, Gopal Krishana Bohra |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 57 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |